Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Apixaban in AF and CAD
NCT07753200Phase 4Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jul 2026
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in Atrial fibrillation (AFib), coronary artery disease (CAD), sponsored by Samsung Medical Center. Started Jul 2026; status: recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07753200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753200.